Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study (2022)
Attributed to:
Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.08.15.22278752
Publication URI: http://dx.doi.org/10.1101/2022.08.15.22278752
Type: Preprint